1. Home
  2. EARN vs CBUS Comparison

EARN vs CBUS Comparison

Compare EARN & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • CBUS
  • Stock Information
  • Founded
  • EARN 2012
  • CBUS 2010
  • Country
  • EARN United States
  • CBUS United States
  • Employees
  • EARN N/A
  • CBUS N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • CBUS Agricultural Chemicals
  • Sector
  • EARN Real Estate
  • CBUS Industrials
  • Exchange
  • EARN Nasdaq
  • CBUS Nasdaq
  • Market Cap
  • EARN 189.7M
  • CBUS 72.0M
  • IPO Year
  • EARN 2013
  • CBUS 2017
  • Fundamental
  • Price
  • EARN $5.29
  • CBUS $1.61
  • Analyst Decision
  • EARN Buy
  • CBUS Strong Buy
  • Analyst Count
  • EARN 2
  • CBUS 2
  • Target Price
  • EARN $5.88
  • CBUS $21.25
  • AVG Volume (30 Days)
  • EARN 366.9K
  • CBUS 832.2K
  • Earning Date
  • EARN 11-11-2025
  • CBUS 11-06-2025
  • Dividend Yield
  • EARN 17.94%
  • CBUS N/A
  • EPS Growth
  • EARN N/A
  • CBUS N/A
  • EPS
  • EARN N/A
  • CBUS N/A
  • Revenue
  • EARN $35,893,000.00
  • CBUS $4,846,000.00
  • Revenue This Year
  • EARN N/A
  • CBUS $17.67
  • Revenue Next Year
  • EARN $15.96
  • CBUS $63.43
  • P/E Ratio
  • EARN N/A
  • CBUS N/A
  • Revenue Growth
  • EARN 43.30
  • CBUS 63.66
  • 52 Week Low
  • EARN $4.33
  • CBUS $1.20
  • 52 Week High
  • EARN $7.11
  • CBUS $6.10
  • Technical
  • Relative Strength Index (RSI)
  • EARN 47.68
  • CBUS 56.27
  • Support Level
  • EARN $5.10
  • CBUS $1.43
  • Resistance Level
  • EARN $5.20
  • CBUS $1.71
  • Average True Range (ATR)
  • EARN 0.10
  • CBUS 0.14
  • MACD
  • EARN 0.03
  • CBUS 0.01
  • Stochastic Oscillator
  • EARN 64.41
  • CBUS 39.48

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: